Reducing Infarct Size in STEMI
By Andy Skean Senior Editor Myocardial infarct size is a key determinant of cardiac...
Read More
myocardial infarction
Anxiety, depression tied to higher risk of heart attack, stroke
By Lisa Rapaport (Reuters Health) – Adults with mood disorders like anxiety and depression...
Read More
A Closer Look at MI Among Younger Women
Over time, the frequency of myocardial infarction (MI) in the United States has been declining...
Read More
UA/NSTEMI: A Guideline Update
Following the recent FDA approval of new medications to reduce cardiovascular death and heart...
Read More
Heart Attack Patients Not Receiving Evidence-Based Treatment
Among patients with acute myocardial infarction, a large analysis has found that four variables...
Read More
Optimizing Chest Pain Diagnoses in the ED
An estimated 8 million people present to EDs in the United States with chest pain each year, 15%...
Read More
Tailoring Antiplatelet Treatment
Important advances have occurred in our understanding of the platelets’ role in arterial...
Read More
Revascularizing Occluded Arteries: Assessing the Influence of Guidelines
The Occluded Artery Trial (OAT) was a large, randomized controlled study funded by the National...
Read More
Can Hypothermia Benefit Post-MI Patients?
A small American study suggests that systemic therapeutic hypothermia can decrease morbidity and...
Read More
Will No Co-Pay Improve Medication Adherence?
Will full health plan coverage of prescription medications improve patient adherence to...
Read More
Analyzing Poor Medication Adherence After MI
Approximately, 1.5 million cases of myocardial infarction (MI) occur each year. An estimated 5% to...
Read More
Adopting Aldosterone Antagonist Therapy
Randomized clinical trials on the use of aldosterone antagonists in eligible patients with heart...
Read More